What European Founders Get Wrong About US Fundraising
The capital is there. The approach usually isn't.
March 10, 2026 · 3 min read · Gyula Lukacs
European founders often arrive in the United States with a strong product, a solid balance sheet, and a pitch built for the wrong audience. The most common mistake is not the deck — it is the assumption that American investors evaluate companies the way European ones do.
European investors tend to reward proof: revenue history, capital efficiency, a conservative plan you can defend line by line. American investors — particularly at the growth stage — are buying a story about scale. They want to know how big this becomes, how fast, and why your team is the one that gets there first. A pitch that leads with prudence reads, to a US ear, as a pitch that lacks ambition.
The second mistake is underestimating the relationship timeline. US fundraising is a campaign, not an event. The investors who write checks are usually the ones who have watched a company perform for two or three quarters after a first, informal conversation. Founders who fly in for two weeks of meetings and fly home rarely close anything — not because the meetings went badly, but because there was no one on the ground when the follow-up mattered.
Third: the entity question comes up earlier than most founders expect. Many US funds are reluctant to invest in a European parent company. Flipping into a Delaware structure late in a process costs time and negotiating leverage. Resolving this early — with specialist legal and tax counsel, before the first term sheet rather than after — keeps the conversation about the business, where it belongs.
None of these are reasons to stay home. The US market rewards European companies that arrive prepared: a story sized to the market, a presence that persists between meetings, and a structure investors recognize. The capital is there. Most of what stands between a European founder and that capital is not quality — it is translation.